CAR-T Cell Therapy Is Here To Stay

Published: Jul 19, 2017

After decades of research and development, we’re on the brink of a new era in the treatment of cancer, one where nearly every aspect—from the patient experience to the efficacy of treatments—may be upended. This treatment is known as chimeric antigen receptor T-cell (CAR-T) therapy and represents a completely new kind of immunotherapy medicine.

Back to news